Detalhe da pesquisa
1.
A phase I clinical trial of a new 5-valent rotavirus vaccine
Vaccine;
31(7): 1100-1105, Feb. 2013.
Artigo
em Inglês
| SES-SP, SESSP-IIERPROD, SES-SP | ID: biblio-1068360
2.
Immunogenicity and Reactogenicity of 2009 Influenza A (H1N1) Inactivated Monovalent Non-Adjuvanted Vaccine in Elderly and Immunocompromised Patients
PLos ONE;
6(11): 1-7, Nov 8, 2011.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP, SESSP-IBACERVO | ID: biblio-1065092
3.
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1)inactivated monovalent vaccines with different adjuvant systems
Vaccine;
29(48): 8974-8981, Sept 21, 2011.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP, SESSP-IBACERVO | ID: biblio-1068354
4.
Influenza vaccine production for Brazil: A classic example of successful NorthSouth bilateral technology transfer
Vaccine;
29(supl.1): 12-15, Jul 1 ,2011.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP, SESSP-IBACERVO | ID: biblio-1068358
5.
Acellular and "low" pertussis vaccines: adverse events and the role of mutations / Vacinas pertussis acelular e pertussis "low": eventos adversos e o papel das mutações
Rev. Inst. Med. Trop. Säo Paulo;
51(3): 131-134, May-June 2009. ilus
Artigo
em Inglês
| LILACS, SES-SP | ID: lil-517095
6.
Analysis of the immunogenicity and stability of a porcine pulmonary surfactant preparation administered in rabbits
Clinics;
61(2): 153-160, Apr. 2006. graf
Artigo
em Inglês
| LILACS, SES-SP | ID: lil-426297